Skip to main content
Article thumbnail
Location of Repository

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial

By Gerhard Wikstrom, Carina Blomström-Lundqvist, Bertil Andren, Stefan Lönnerholm, Per Blomström, Nick Freemantle, Thomas Remp and John G.F. Cleland
Topics: Clinical Research
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2006). AgricolaE,OppizziM,GalderisiM,PisaniM,Meris A,Pappone C,MargonatoA.Role ofregionalmechanicaldyssynchronyasdeterminantoffunctionalmitralregurgitation in patients with left ventricular systolic dysfunction.
    2. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (Cardiac Resynchronisation Heart Failure study).
    3. BaxJ.Effectoftotalscarburdenoncontrast-enhancedmagneticresonanceimaging on response to cardiac resynchronization therapy.
    4. (2007). Cardiac resynchronization therapy or atriobiventricular pacing—what should it be called? Nat Clin Pract Cardiovasc Med
    5. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure.
    6. CARE-HF Investigators. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    7. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration.
    8. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth.
    9. (2005). Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization. Pacing Clin Electrophysiol
    10. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    11. Effects of biventricular pacing on myocardial blood flow and oxygen consumption using carbon-11 acetate positron emission tomography in patients with heart failure.
    12. Extent of myocardial viability predicts response tobiventricularpacinginischemiccardiomyopathy.HeartRhythm2005;2:1211–1217.
    13. Feldman AM; Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defi-brillator in advanced chronic heart failure.
    14. Is the prognosis of heart failure improving?
    15. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy.
    16. (2005). Long-term ventricular reverse remodelling with cardiac resynchronisation therapy. Results from the CARE-HF Trial. (Abstract). Circulation
    17. Myocardial systolic activation delay in patients with left bundle branch block and either normal or impaired left ventricular function.
    18. Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? Heart Fail Rev 2004;9: 337–345. Discussion 347–351.
    19. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony.
    20. Papillary muscle dysfunction attenuates ischemic mitral regurgitation in patients with localized basal inferior left ventricular remodeling: insights from tissue Doppler strain imaging.
    21. (2005). Prevalence of intraventricular dyssynchrony increases with stress. (Abstract). Circulation
    22. (2004). Steering Committee and Investigators. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
    23. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology.
    24. Tavazzi L; CARE-HF Study Steering Committee Investigators. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points.
    25. (2005). Three year outcome of cardiac resynchronization therapy: a single center evaluation. Pacing Clin Electrophysiol
    26. (2005). Titin: physiological function and role in cardiomyopathy and failure. Heart Fail Rev

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.